GLP-1 medications can possibly reduce thirst, leading to less saliva and xerostomia, or dry mouth
There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis associated with GLP-1RA use compared to usual care
Intriguingly, LL-37 also has anti-inflammatory properties in certain contexts, making it a dual-natured molecule
[PubMed] [Springer] ASHP, Acetylcysteine (Monograph)
A blue nevus is comprised of arrested dendritic melanocytes within the dermis and the deep location results in a bluish-black clinical appearance due to the Tyndall effect of light scattering
"All of these dynamics suggest GLP-1 drugs' impact across consumer sectors is set to increase as drug uptake grows and the drugs reshape behavior among a demographic group that represents a disproportionate share of calorie consumption." But many food and beverage companies have reassured investors over the last few months that it's still unclear how much those drugs will lower their revenue
